Micheal Clements, NAFB News Service
The Senate Health Committee will vote on Stephen Hahn’s nomination to serve as Commissioner of the Food and Drug Administration next week. Tuesday, the committee will consider the nomination, among three others. If approved, the nominations would head for the full Senate for a final confirmation vote. During a hearing by the committee examining the nomination, Hahn briefly voiced his support for “clear, transparent, and understandable labeling” for dairy and dairy imitation products. The comments were welcomed by the National Milk Producers Federation, as NMPF CEO Jim Mulhern stated, “It’s heartening to hear” Hahn would “immediately examine this crucial unfinished business.” NMPF and others are seeking a labeling system that prohibits plant-based dairy imitators from using dairy marketing terms. Rules already do so, but FDA has not enforced them. Committee Chairman Lamar Alexander, a Republican from Tennessee, called Hahn an “impressive choice” to lead the FDA. Ranking member Patty Murray, a Democrat from Washington, demanded Hahn commit to putting science, data and families first.